TXA | News

Home  ›  TXA | News

Latest News

Injured Women Half as Likely as Men to Receive Tranexamic Acid
Cost-effectiveness of TXA for older adults experiencing mild traumatic brain injury
Healthy volunteer trial looking at pharmacokinetics of TXA in alternate routes, shows IM TXA to be an efficient alternative to IV
‘HER LIFE MATTERS’ DOCUMENTARY IS LIVE
WOMAN-2 Trial
Art for Maternal Health Awareness
A CRASH-3 Trial Sub-Study Provides Evidence of TXA Benefit in TBI
World Day of Remembrance for Road Traffic Victims
WOMAN-PharmacoTXA Trial
World Health Organization reacts to the WOMAN Trial results
Trauma-INTACT Results
Nigerian Health Minister To Support the WOMAN-trial

Our Recent Posts

TXA CENTRAL_EMERGENCY-EXTRACRANIAL BLEEDING
Trauma-INTACT Results
November 27, 2020 Uncategorized admin

The Trauma Intact trial: a clinical trial investigating pharmacokinetics of intramuscular tranexamic acid (TXA) in bleeding trauma patients TXA a drug that prevents severe bleeding after injury by inhibiting blood clot breakdown, is most effective when given soon after injury. Every 15 minutes treatment delay reduces its lifesaving potential by 10%. However, currently only 3%

Details
WOMAN TRIAL TRANEXAMIC ACID RESEARCH TXA CLINICAL TRIAL PPH MATERNAL WOMEN HEALTH
Nigerian Health Minister To Support the WOMAN-trial
November 18, 2020 Uncategorized admin

Nigeria’s health minister, Professor Isaac Adewale has said that deaths of women due to postpartum haemorrhage (PPH), a severe form of bleeding after childbirth, was a huge problem in Nigeria and that he will promote the use of tranexamic acid to reduce these deaths. “This drug is not new in Nigeria, but now we want

Details